Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis
出版年份 2021 全文链接
标题
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis
作者
关键词
-
出版物
AMERICAN JOURNAL OF KIDNEY DISEASES
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-03-27
DOI
10.1053/j.ajkd.2021.03.007
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy
- (2019) Aliza Thompson et al. Clinical Journal of the American Society of Nephrology
- Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
- (2019) Hiddo J L Heerspink et al. Lancet Diabetes & Endocrinology
- GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials
- (2019) Lesley A. Inker et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Performance of GFR Slope as a Surrogate Endpoint for Kidney Disease Progression in Clinical Trials: A Statistical Simulation
- (2019) Tom Greene et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data
- (2019) Morgan E. Grams et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mixed‐effects models for slope‐based endpoints in clinical trials of chronic kidney disease
- (2019) Edward Vonesh et al. STATISTICS IN MEDICINE
- Change in Albuminuria and Estimated GFR as End Points for Clinical Trials in Early Stages of CKD: A Perspective From European Regulators
- (2019) Frank Holtkamp et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Change in Estimated GFR and Albuminuria as End Points in Clinical Trials: A Viewpoint From the FDA
- (2019) Aliza Thompson et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy
- (2017) Jicheng Lv et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis
- (2016) Lesley A. Inker et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Intensive Supportive Care plus Immunosuppression in IgA Nephropathy
- (2015) Thomas Rauen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Conducting Meta-Analyses inRwith themetaforPackage
- (2015) Wolfgang Viechtbauer Journal of Statistical Software
- Early Change in Proteinuria as a Surrogate End Point for Kidney Disease Progression: An Individual Patient Meta-analysis
- (2014) Lesley A. Inker et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- GFR Decline as an Alternative End Point to Kidney Failure in Clinical Trials: A Meta-analysis of Treatment Effects From 37 Randomized Trials
- (2014) Lesley A. Inker et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
- (2014) Andrew S. Levey et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
- (2014) Josef Coresh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
- (2014) Rosanna Coppo et al. KIDNEY INTERNATIONAL
- Risk factors for persistent proteinuria after a 2-year combination therapy for severe childhood IgA nephropathy
- (2014) Koichi Kamei et al. PEDIATRIC NEPHROLOGY
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Risk Stratification of Patients With IgA Nephropathy
- (2012) Sean J. Barbour et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy
- (2012) Miho Tatematsu et al. Clinical and Experimental Nephrology
- The predictive value of attenuated proteinuria at 1 year after steroid therapy for renal survival in patients with IgA nephropathy
- (2012) Keita Hirano et al. Clinical and Experimental Nephrology
- IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine
- (2012) Claudio Pozzi et al. JOURNAL OF NEPHROLOGY
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
- (2012) Vicente E. Torres et al. NEW ENGLAND JOURNAL OF MEDICINE
- Addition of Azathioprine to Corticosteroids Does Not Benefit Patients with IgA Nephropathy
- (2010) C. Pozzi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification
- (2009) Daniel C. Cattran et al. KIDNEY INTERNATIONAL
- Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy
- (2009) C. Manno et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search